Search research articles
Contact Us
Filters
Showing results (31-40 of 265) with videos related to
Page
of 27
Sort By:
BMJ (Clinical Research Ed.)
|
April 16, 2002
Selling sickness: the pharmaceutical industry and disease mongering
Ray Moynihan, Iona Heath, David Henry
Blood Advances
|
January 4, 2018
Ovarian vein thrombus: to treat or not to treat?
Trisha Plastini, David Henry, Katie Dunleavy
BMJ (Clinical Research Ed.)
|
May 31, 2012
Preventing overdiagnosis: how to stop harming the healthy
Ray Moynihan, Jenny Doust, David Henry
Clinical Pharmacokinetics
|
April 15, 2004
Single-enantiomer drugs: elegant science, disappointing effects
Peter Mansfield, David Henry, Anne Tonkin
Social Science & Medicine (1982)
|
January 18, 2005
Moral hazard and prescription medicine use in Australia--the patient perspective
Evan Doran, Jane Robertson, David Henry
Plos Medicine
|
May 30, 2008
Disease mongering is now part of the global health debate
Ray Moynihan, Evan Doran, David Henry
Prevention Science : the Official Journal of the Society for Prevention Research
|
February 24, 2015
Increasing the Sensitivity of Measures to Change
Carlotta Ching Ting Fok, David Henry
International Journal of Epidemiology
|
February 2, 2018
Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs
Paulina Stehlik, Laura Rosella, David Henry
Healthcarepapers
|
July 28, 2018
Regional Inequalities in All-Cause and Premature Mortality in Ontario
David Henry, Emmalin Buajitti, Laura Rosella
BMC International Health and Human Rights
|
October 16, 2009
Increasing the demand for childhood vaccination in developing countries: a systematic review
Beverley Shea, Neil Andersson, David Henry
Page
of 27
Search research articles
Search
Showing results (31-40 of 265) with videos related to
Sort By:
Page
of 27
BMJ (Clinical Research Ed.)
|
April 16, 2002
Selling sickness: the pharmaceutical industry and disease mongering
Ray Moynihan, Iona Heath, David Henry
Blood Advances
|
January 4, 2018
Ovarian vein thrombus: to treat or not to treat?
Trisha Plastini, David Henry, Katie Dunleavy
BMJ (Clinical Research Ed.)
|
May 31, 2012
Preventing overdiagnosis: how to stop harming the healthy
Ray Moynihan, Jenny Doust, David Henry
Clinical Pharmacokinetics
|
April 15, 2004
Single-enantiomer drugs: elegant science, disappointing effects
Peter Mansfield, David Henry, Anne Tonkin
Social Science & Medicine (1982)
|
January 18, 2005
Moral hazard and prescription medicine use in Australia--the patient perspective
Evan Doran, Jane Robertson, David Henry
Plos Medicine
|
May 30, 2008
Disease mongering is now part of the global health debate
Ray Moynihan, Evan Doran, David Henry
Prevention Science : the Official Journal of the Society for Prevention Research
|
February 24, 2015
Increasing the Sensitivity of Measures to Change
Carlotta Ching Ting Fok, David Henry
International Journal of Epidemiology
|
February 2, 2018
Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs
Paulina Stehlik, Laura Rosella, David Henry
Healthcarepapers
|
July 28, 2018
Regional Inequalities in All-Cause and Premature Mortality in Ontario
David Henry, Emmalin Buajitti, Laura Rosella
BMC International Health and Human Rights
|
October 16, 2009
Increasing the demand for childhood vaccination in developing countries: a systematic review
Beverley Shea, Neil Andersson, David Henry
Page
of 27